ZA863706B - Pyradine derivatives and process for preparing the same - Google Patents

Pyradine derivatives and process for preparing the same

Info

Publication number
ZA863706B
ZA863706B ZA863706A ZA863706A ZA863706B ZA 863706 B ZA863706 B ZA 863706B ZA 863706 A ZA863706 A ZA 863706A ZA 863706 A ZA863706 A ZA 863706A ZA 863706 B ZA863706 B ZA 863706B
Authority
ZA
South Africa
Prior art keywords
sub
preparing
lower alkyl
same
pyradine
Prior art date
Application number
ZA863706A
Other languages
English (en)
Inventor
Takashi Mori
Nobuhiro Ohi
Yoshiyuki Ohsugi
Yasuhiro Yamashita
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA863706B publication Critical patent/ZA863706B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA863706A 1985-05-23 1986-05-19 Pyradine derivatives and process for preparing the same ZA863706B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11064285 1985-05-23

Publications (1)

Publication Number Publication Date
ZA863706B true ZA863706B (en) 1987-01-28

Family

ID=14540880

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA863706A ZA863706B (en) 1985-05-23 1986-05-19 Pyradine derivatives and process for preparing the same

Country Status (14)

Country Link
US (1) US4691018A (ja)
EP (1) EP0203435B1 (ja)
JP (1) JPS6253966A (ja)
KR (1) KR860008980A (ja)
CN (1) CN86103501A (ja)
AT (1) ATE55992T1 (ja)
AU (1) AU587251B2 (ja)
CA (1) CA1240332A (ja)
DE (1) DE3673693D1 (ja)
ES (1) ES8707934A1 (ja)
HU (1) HU195486B (ja)
SU (1) SU1419517A3 (ja)
YU (1) YU83686A (ja)
ZA (1) ZA863706B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
US4904657A (en) * 1987-09-24 1990-02-27 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds exhibiting therapeutic activities
JP2746832B2 (ja) * 1993-05-14 1998-05-06 大鵬薬品工業株式会社 眼局所抗アレルギー剤
TW264385B (ja) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
US20120195929A1 (en) * 2009-06-04 2012-08-02 George Eisenbarth Compounds that modulate autoimmunity and methods of using the same
WO2012162697A1 (en) 2011-05-26 2012-11-29 The Regents Of The University Of Colorado, A Body Corporate Compounds that modulate autoimmunity and methods of using the same
EP2890349B1 (en) 2012-08-30 2017-03-08 Huntleigh Technology Limited Multi-layered patient support cover sheet system
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
WO2017165508A1 (en) 2016-03-24 2017-09-28 Im Therapeutics Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057797B1 (en) * 1981-02-03 1986-06-25 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
JPS58105920A (ja) * 1981-12-17 1983-06-24 Chugai Pharmaceut Co Ltd 抗癌剤
JPS58159465A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd ピリジン誘導体

Also Published As

Publication number Publication date
EP0203435B1 (en) 1990-08-29
EP0203435A2 (en) 1986-12-03
AU587251B2 (en) 1989-08-10
ES555240A0 (es) 1987-09-01
YU83686A (en) 1988-06-30
HU195486B (en) 1988-05-30
JPS6253966A (ja) 1987-03-09
HUT41735A (en) 1987-05-28
JPH0225906B2 (ja) 1990-06-06
SU1419517A3 (ru) 1988-08-23
US4691018A (en) 1987-09-01
EP0203435A3 (en) 1988-01-07
CA1240332A (en) 1988-08-09
CN86103501A (zh) 1987-01-21
ES8707934A1 (es) 1987-09-01
AU5726786A (en) 1986-11-27
KR860008980A (ko) 1986-12-19
DE3673693D1 (de) 1990-10-04
ATE55992T1 (de) 1990-09-15

Similar Documents

Publication Publication Date Title
HUT49612A (en) Process for producing new 3-alkenyl-1-azabicyclo/3.2.0/ hept-2-ene-2-carboxylic acid derivatives and pharmaceutical compositions comprising same
ES8300112A1 (es) Un procedimiento para preparar compuestos de cefem .
AU581052B2 (en) Preparation process of (6R)-tetrahydro-L-biopterin
ZA863706B (en) Pyradine derivatives and process for preparing the same
NO943093L (no) Fremgangsmåte for fremstilling av clavulansyre
GR3018387T3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
ES8703150A1 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
GB2091723B (en) Derivatives of 2-oxoazetidine-1-sulphonic acid
ES8502099A1 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
ES8603184A1 (es) Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico
NO864635L (no) Nye krystallinske salter av aryloksypropanolaminer, deres fremstilling og anvendelse.
EP0348527A4 (en) Antiallergic eye drop
ES8705439A1 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
AU655869B2 (en) An amphoteric tricyclic compound
ES8707537A1 (es) Un metodo para preparar derivados de acido 2-amino-5-oxo-5h-1 benzopirano 2,3-b piridin-3-carboxilico
EP0367671A3 (en) Novel beta-d-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
FR2583756B1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.
GR852126B (ja)